IP Library Granted Patent US 9,758,557
Granted Patent B2
US 9,758,557 · App. 14/331,301 · Granted Sep 12, 2017

C1q peptides and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,758,557
App. No.
14/331,301
Granted
Sep 12, 2017
Kind
B2
Abstract

Isolated C1q peptides, fusion proteins and compositions comprising such and fusion proteins comprising are provided. Isolated fusion proteins comprising X 4 WX 5 YX 6 as defined herein and compositions comprising such are also provided. Methods of treating autoimmune disorders are provided.

Claims (3)

1. A fusion protein comprising an isolated peptide of 5 to 20 consecutive amino acid residues in length comprising the sequence EADYG (SEQ ID NO:4) joined at an N-terminal amino acid or C-terminal amino acid thereof by a peptide bond to a second peptide or a polypeptide or a protein, which does not comprise WCEADYGRCP (SEQ ID NO:252).

2. The fusion protein of claim 1 , wherein all the amino acid residues of the isolated peptide are D-amino acids.

3. The fusion protein of any of claim 1 , wherein all the amino acid residues of the isolated peptide are L-amino acids.

Assignments (2)
CHANGE OF NAME Recorded Aug 20, 2019
From: THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
To: THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
Reel/Frame 050102/0485 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2014
From: DIAMOND, BETTY A.
To: THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
Reel/Frame 033454/0571 →